Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: CapitalistHogg™ who wrote (806)	2/14/2005 12:39:22 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

This is nice. Should get a nice pop on ENCY Monday. I hope it is good news. The stock has been on a near term uptrend since Jan.31 when it started to move up from the 9.20 level. It has resistance at the 11.01 level and then at the Dec.3 H (11.94) If it can close above that level it seems it could get to test the $15 The Nov.2000 H at $17.39 doesn't look that far since there isn't too much resistance above the $12 level.<g> The stock was up 6.16% during regular hours on Friday and also did well in after hours trading. (Up $0.59) bigcharts.marketwatch.com bigcharts.marketwatch.com ENCY reportedly has $1.40 in cash/share and its Debt/Equity Ratio is around 0.02 Besides releasing results of its PIII on Thelin for PAH tomorrow it is also scheduled to present at Smith Barney's Small & Mid-Cap Conference in Las Vegas, on Wednesday and will release its year end 2004 earnings results on Thursday. (It seems it will have a bussy week.<g>) The CC on February 17, 2005 at 4:30PM can be heard at:(612) 288-0318 Passcode: Encysive Pharmaceuticals It is expected that results of Thelin on this PIII will be better than results from a different PIII reported in Dec.when the drug (at a low dose), was less effective than placebo as a treatment for PAH.<g> Bernard